Abstract:Abstract Background: HER2/neu overexpression in breast cancer confers a lipogenic phenotype. Although the introduction of anti-Her2 therapies has led to dramatic improvements in survival, nearly all patients with metastatic Her2-positive breast cancer will progress on treatment suggesting the importance of developing coextinction approaches targeting multiple pathways. Peroxisome proliferator-activated receptor γ (PPARγ), which is expressed in a variety of malignancies, governs biological functions through transcriptional programs. PPARγ binds additional DNA cis elements associated with other transcription factors, including C/EBPs, NFκB and AP-1 proteins, to promote non-canonical signaling. Defining the mechanisms governing the selection of canonical versus non-canonical PPARγ binding sequences may provide the opportunity to design regulators with distinct functions and side effects. PPARγ1 acetylation at K268/293 participates in the regulation of adipose tissue differentiation (1), and the conserved lysine residues (K154/155) govern lipogenesis in breast cancer cells (2). Although Cre based Pparγ1 gene deletion in mammary tumor oncomice showed Pparγ1 participates in the onset and progression of ErbB2-induced mammary tumorigenesis (3), the molecular mechanisms and the post-translational modifications of PPARγ governing Pparγ1 tumorigenic function remained to be determined. Methods: Herein, we defined the role of PPARγ1 acetylation in breast cancer growth in immune-deficient mice using distinct breast cancer cell lines (MCF10-Ras, MCF10A-NeuT). Furthermore, using ChIP and ChIP-Seq we show that the acetylated residues of Pparγ1 altered preference of cis-element binding in chromatin to augment Pparγ non-canonical binding. Results: Herein, the PPARγ1 acetylated residues K154/155 were shown to be essential for the induction of transcriptional modules governing growth factor signaling, cellular apoptosis, and autophagy in mice. The K154/155 residues determined the selection of genome-wide DNA binding sites, altering the selection from canonical to non-canonical (C/EBP) DNA sequence-specific binding. The gene signature reflecting the acetylation-dependent genomic occupancy provided predictive value in patient survival outcomes. Conclusions: Endogenous Pparγ1 promotes mammary tumor onset and progression. PPARγ1 breast tumor induction involves K154/155, which governs transcriptional programs (growth, apoptosis, and autophagy) via transcriptional complex binding to canonical vs. non-canonical regulatory elements. Pparγ1 acetylation participates in ErbB2-induced breast cancer tumor growth and inflammation and may represent a relevant target for therapeutic coextinction. References: (1) Qiang L, et al. Cell 2012;150:620-322. (2) Tian L, et al. Oncotarget 2014;5:7303-153. (3) Jiao X, et al. Cancers (Basel) 2021;13. Citation Format: LIfeng Tian, Xuanmao Jiao, Chenguang Wang, Adam Ertel, Raymond Soccio, Eric R. Chen, Balázs Győrffy, Gabriele Di Sante, Zhijiu Zhong, Sankar Addya, Peter A. McCue, Andrew V. Kossenkov, Joanna Achinger-Kawecka, Susan Clark, Richard G. Pestell. PPAR gamma acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3582.

Phosphorylation at Tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is Required for Adipogenesis in Response to High Fat Diet.

Loss of tyrosine 211 phosphorylation of proliferating cell nuclear antigen (PCNA) enhances postnatal mammary gland development

Phosphorylation of Proliferating Cell Nuclear Antigen Promotes Cancer Progression by Activating the ATM/Akt/GSK3β/Snail Signaling Pathway.

Gcn5 and PCAF regulate PPARγ and Prdm16 expression to facilitate brown adipogenesis.

Sequential Phosphorylation Of Ccaat Enhancer-Binding Protein Beta By Mapk And Glycogen Synthase Kinase 3 Beta Is Required For Adipogenesis

The Functions of PCNA in Tumor Stemness and Invasion

Phosphorylation Prevents C/EBPβ from the Calpain-Dependent Degradation

PCNA Phosphorylation at Tyrosine211 Inhibits Mismatch Repair at the Initiation Step

The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy

Proliferating cell nuclear antigen (PCNA): ringmaster of the genome

Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses

TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation

Abstract 3582: PPAR gamma acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding

Mice with an Adipocyte-Specific Lipin 1 Separation-of-function Allele Reveal Unexpected Roles for Phosphatidic Acid in Metabolic Regulation

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis

Abstract 2690: The role of PCNA tyrosine phosphorylation in evading innate immune surveillance

WIP1 phosphatase is a critical regulator of adipogenesis through dephosphorylating PPARγ serine 112

311-OR: Role of Pcpe2 in Adipose Tissue Remodeling and Expansion

Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities

Evaluation of protein phosphorylation during adipogenesis.

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment to influence gene expression during beige adipogenesis